Abstract:Aims: To compare how OCT4A proteins interact with and regulate multiple OCT4A-octamer motifs (OMs) in different regions of the FOS gene expressed in somatic cancer cells versus pluripotent stem cells. Materials and methods: Two FOS reporter gene systems harboring predicted OMs or their mutational counterparts were introduced into HeLa and NCCIT cells with varying OCT4A protein levels. The transcription of dsGFP reflecting FOS expression was quantitated by RT-qPCR, the OCT4A-OMs binding and the correlation between OCT4A and FOS transcription was determined by ChIP-PCR and RNA-Seq, respectively. Key findings: In NCCIT cells, abundant OCT4A proteins bound to and inhibited OM1 and OM2 at the promoter of the FOS gene. RA-induced OCT4A down-regulation transiently increased FOS transcription. In contrast, in HeLa cells that contain much lower levels of endogenous OCT4A proteins, OCT4A primarily bound to and activate OM1 thereby promoting FOS transcription. OCT4A KO significantly reduced FOS expression. Ectopically introduced OCT4A, at its leaked or induced expression level, promoted FOS transcription by binding to OM2/OM3 or OM1/OM3, respectively. Thus, the interaction of OCT4A proteins with different OMs is cellular context- and protein level-dependent, and such complicated OCT4A binding mode can only be reflected by a dsGFP-based reporter harboring the full-length FOS gene but not by that merely having the FOS promoter. Significance: Our findings unravel an additional layer of regulatory mechanisms that account for the cellular context- and dose-related versatile functions of OCT4A protein, and further underscore the importance of precise modulation of OCT4A in the regenerative medicine and anticancer therapies.

A suboptimal OCT4-SOX2 binding site facilitates the naïve-state specific function of a Klf4 enhancer

MLL4 Prepares the Enhancer Landscape for Foxp3 Induction Via Chromatin Looping

Enhancer priming by H3K4 methyltransferase MLL4 controls cell fate transition.

Site-Specific Disruption of the Oct4/Sox2 Protein Interaction Reveals Coordinated Mesendodermal Differentiation and the Epithelial-Mesenchymal Transition

Cellular Context- and Protein Level-Dependent Interaction of Pluripotency Factor OCT4A with Multiple Octamer Motifs of the Same Target Gene

Oct4 Switches Partnering from Sox2 to Sox17 to Reinterpret the Enhancer Code and Specify Endoderm

Divergent roles for KLF4 and TFCP2L1 in Naive Ground State Pluripotency and Human Primordial Germ Cell Development

The TFAP2C-Regulated OCT4 Naive Enhancer is Involved in Human Germline Formation.

Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem Cells

Multifaceted SOX2-chromatin interaction underpins pluripotency progression in early embryos

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

TFAP2C regulates transcription in human naive pluripotency by opening enhancers

Dynamic regulation of chromatin accessibility by pluripotency transcription factors across the cell cycle

Enhancer-promoter association determines Sox2 transcription regulation in mouse pluripotent cells

Heterochromatin Loosening by the Oct4 Linker Region Facilitates Klf4 Binding and Ipsc Reprogramming.

Pluripotency Reprogramming by Competent and Incompetent POU Factors Uncovers Temporal Dependency for Oct4 and Sox2.

Live-Cell Imaging Reveals Enhancer-dependent Sox2 Transcription in the Absence of Enhancer Proximity

Co-Motif Discovery Identifies an Esrrb-Sox2-DNA Ternary Complex As a Mediator of Transcriptional Differences Between Mouse Embryonic and Epiblast Stem Cells

Analysis of A Transgenic Oct4 Enhancer Reveals High Fidelity Long-Range Chromosomal Interactions

A balanced Oct4 interactome is crucial for maintaining pluripotency

Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.